239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship

BACKGROUND: Aztreonam is often given to patients with a documented β-lactam allergy in lieu of a first-line anti-pseudomonal β-lactam (APBL). However, aztreonam offers no gram positive coverage and data suggest that gram negative organisms have lower susceptibility rates to this antibiotic than to A...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaffa, Rupal K, Pillinger, Kelly E, Medaris, Leigh A, Anderson, William E, Heffner, Alan C, Hammer, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776438/
http://dx.doi.org/10.1093/ofid/ofaa439.283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776438/
http://dx.doi.org/10.1093/ofid/ofaa439.283

Ejemplares similares